The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
Citations Over TimeTop 10% of 2017 papers
Abstract
The current vaccine against tuberculosis, live attenuated Mycobacterium bovis BCG, has variable efficacy, but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. There has been a recent resurgence of interest in functional in vitro mycobacterial growth inhibition assays (MGIAs), which provide a measure of a range of different immune mechanisms and their interactions. We identified a positive correlation between mean corpuscular haemoglobin and in vitro growth of BCG in whole blood from healthy UK human volunteers. Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both humans and macaques was increased following the experimental addition of haemoglobin (Hb) or ferric iron, and reduced following addition of the iron chelator deferoxamine (DFO). Expression of Hb genes correlated positively with mycobacterial growth in whole blood from UK/Asian adults and, to a lesser extent, in PBMC from South African infants. Taken together our data indicate an association between Hb/iron levels and BCG growth in vitro, which may in part explain differences in findings between whole blood and PBMC MGIAs and should be considered when using such assays.
Related Papers
- → Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis(2018)289 cited
- → TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo(2016)12 cited
- → Comparison of exchange transfusion and deferoxamine in the treatment of acute iron poisoning(1969)24 cited
- Suppression of HL-60 cell proliferation by deferoxamine: changes in c-myc expression.(1993)
- → Deferoxamine toxicity in hepatoma and primary rat cortical brain cultures(2001)6 cited